Literature DB >> 12029454

Malignant rhabdoid tumour of the kidney occurring simultaneously with a brain tumour: a report of two cases and review of the literature.

Chih-Cheng Luo1, Jer-Nan Lin, Tang-Her Jaing, Chao-Ping Yang, Chuen Hsueh.   

Abstract

UNLABELLED: Malignant rhabdoid tumour of the kidney (MRTK), an uncommon aggressive neoplasm of children, is now recognised as a separate entity from Wilms' tumour with distinct clinical and pathological features. MRTK is unique in its significant association with primary brain tumours or brain metastases. We report two cases, aged 2 and 6 months, of MRTK occurring concurrently with a brain tumour. Radical nephrectomy and ventriculo-peritoneal shunting were performed. Both patients expired 2 and 6 months later despite receiving aggressive post-operative chemotherapy and radiotherapy.
CONCLUSION: malignant rhabdoid tumour of the kidney is an uncommon neoplasm of early childhood with a poor prognosis. Due to its significant association with brain tumours or early brain metastases, concurrent brain computer tomographic examination is essential for all patients with this disease.

Entities:  

Mesh:

Year:  2002        PMID: 12029454     DOI: 10.1007/s00431-002-0918-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  3 in total

1.  Malignant rhabdoid tumor of the kidney and spine in an infant.

Authors:  Sejun Park; Jae-Hee Seo; Jun Bum Park; Sungchan Park
Journal:  J Korean Neurosurg Soc       Date:  2014-01-31

2.  Co-existent Rhabdoid Tumor of The Kidney and Brain in a Male Infant: A Rare Case.

Authors:  Faryal Tahir; Zainab Majid; Laila Tul Qadar; Awais Abbas; Mohammad Raza
Journal:  Cureus       Date:  2019-08-19

3.  Imaging features and differences among the three primary malignant non-Wilms tumors in children.

Authors:  Yupeng Zhu; Wangxing Fu; Yangyue Huang; Ning Sun; Yun Peng
Journal:  BMC Med Imaging       Date:  2021-12-01       Impact factor: 1.930

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.